APA (7th ed.) Citation

L, X., M, K., E, R., A, B., A, K., A, E., . . . K, S. (2022). The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression. Frontiers in oncology, 12, 863329. https://doi.org/10.3389/fonc.2022.863329

Chicago Style (17th ed.) Citation

L, Xiao, et al. "The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression." Frontiers in Oncology 12 (2022): 863329. https://doi.org/10.3389/fonc.2022.863329.

MLA (9th ed.) Citation

L, Xiao, et al. "The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression." Frontiers in Oncology, vol. 12, 2022, p. 863329, https://doi.org/10.3389/fonc.2022.863329.